Clinical Trials List
Protocol NumberLOXO-IDH-20001
NCT Number(ClinicalTrials.gov Identfier)-
Completed
2021-01-01 - 2024-12-31
Phase I
Recruiting2
-
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
- Ching-Chan Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
HSIN-AN HOU
Co-Principal Investigator
- MING YAO Division of General Internal Medicine
- Wen-Chien Chou Division of Others -
- Chien-Chin Lin Division of Others -
- Chieh-Lung Cheng Division of General Internal Medicine
- - - Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- 劉家豪 Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- SHAN-CHI YU Division of Others -
- - - Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
260 participants
